Medtronic PLC (MDT) Stock Forecast
US · Healthcare
Current price
$80.52
Market cap
$103.07B
Mean price target
$98.00
Implied upside
21.7%
Key takeaways
- Analysts rate Medtronic PLC a “Buy”, with a mean price target of $98.00 — about 21.7% upside from the current $80.52, based on 26 analysts.
- MDT is trading in the middle of its 52-week range, at 22% of the $73.31–$106.33 band.
Analyst consensus
| Consensus rating | Buy |
|---|---|
| Number of analysts | 26 |
| Mean target | $98.00 |
| High target | $121.00 |
| Low target | $78.00 |
| Rating split (SB / B / H / S / SS) | 4 / 14 / 13 / 0 / 0 |
Price & trading
| Current price | $80.52 |
|---|---|
| Previous close | $80.13 |
| 52-week high | $106.33 |
| 52-week low | $73.31 |
| 50-day average | $79.67 |
| Beta | 0.60 |
See the full MDT breakdown on Luminoso
Valuation, profitability, efficiency, leverage & earnings-quality metrics — updated daily.
Start free — 2 months on usFrequently asked questions
- What is the current Medtronic PLC (MDT) share price?
- Medtronic PLC last traded at $80.52 with a market capitalisation of about $103.1B.
- What is the analyst price target for MDT?
- The mean analyst price target for Medtronic PLC is $98.00, roughly 21.7% above the latest price. The current consensus rating is “Buy”.
- Where can I see Medtronic PLC's full financial metrics?
- Luminoso tracks MDT's valuation, profitability, efficiency, leverage and earnings-quality metrics alongside analyst data — updated daily. Create a free account to explore the full breakdown.
More stocks
Browse all companies covered by Luminoso →
Last updated 25 Jun 2026.
Data is provided for informational purposes only and is not investment advice. Figures are cached and refreshed daily; they may differ from real-time quotes.